🇺🇸 FDA
Pipeline program

TTX-MC138-NODAGA-Cu64

TTX-MC138-NODAGA-Cu64-001

Phase 1 small_molecule completed

Quick answer

TTX-MC138-NODAGA-Cu64 for Advanced Solid Tumor is a Phase 1 program (small_molecule) at Transcode Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Transcode Therapeutics
Indication
Advanced Solid Tumor
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials